Effect of Lutetium-177 Dota Octreotate Peptide Receptor Radionuclide Therapy in Patients With Advanced Neuroendocrine Tumors and Carcinoid Syndrome Refractory to Somatostatin Analogues

被引：0
|
作者：
Koffas, Apostolos
Popat, Rickin
Demetriou, George
Quigley, Ann-Marie
Navalkissoor, Shaunak
Caplin, Martyn
Toumpanakis, Christos
机构：
来源：
GASTROENTEROLOGY | 2016年 / 150卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(16)30774-0
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1059
引用
收藏
页码：S208 / S208
页数：1
相关论文
共 50 条
  • [21] Peptide receptor radionuclide therapy with 177Lu-DOTATATE for patients with somatostatin receptor-expressing neuroendocrine tumors
    Abou Jokh Casas, E.
    Pombo Pasin, M. D.
    Pubul Nunez, V.
    Garrido Pumar, M.
    Blanco Freire, M. N.
    Cabezas, J.
    Cameselle, J.
    Berrios, M.
    Argibay, S.
    Ruibal Morell, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S597 - S598
  • [22] 177 Lu-Dota-octreotate radionuclide therapy of advanced gastrointestinal neuroendocrine tumors: results from a phase II study
    Giovanni Paganelli
    Maddalena Sansovini
    Alice Ambrosetti
    Stefano Severi
    Manuela Monti
    Emanuela Scarpi
    Caterina Donati
    Annarita Ianniello
    Federica Matteucci
    Dino Amadori
    European Journal of Nuclear Medicine and Molecular Imaging, 2014, 41 : 1845 - 1851
  • [23] Lu-177-Based Peptide Receptor Radionuclide Therapy for Advanced Neuroendocrine Tumors
    Kim K.
    Kim S.-J.
    Nuclear Medicine and Molecular Imaging, 2018, 52 (3) : 208 - 215
  • [24] 177 Lu-Dota-octreotate radionuclide therapy of advanced gastrointestinal neuroendocrine tumors: results from a phase II study
    Paganelli, Giovanni
    Sansovini, Maddalena
    Ambrosetti, Alice
    Severi, Stefano
    Monti, Manuela
    Scarpi, Emanuela
    Donati, Caterina
    Ianniello, Annarita
    Matteucci, Federica
    Amadori, Dino
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 (10) : 1845 - 1851
  • [25] Results from OCLURANDOM: the first multicentric randomized phase II trial investigating the antitumor efficacy of peptide receptor radionuclide therapy with lutetium-177 octreotate (OCLU) in patients with unresectable progressive neuroendocrine pancreatic tumors
    Baudin, E.
    Walter, T.
    Beron, A.
    Smith, D.
    Hadoux, J.
    Moreau-Triby, C.
    Taieb, D.
    Ansquer, C.
    Dierickx, L.
    De Mestier, L.
    Deshayes, E.
    Quak, E.
    Dahan, L.
    Guimbaud, R.
    Touchefeu, Y.
    Haissaguerre, M.
    Vuillez, J.
    Courbon, F.
    Hindie, E.
    Do Cao, C.
    Lombard-Bohas, C.
    Attard, M.
    Foulon, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S52 - S52
  • [26] Salvage peptide receptor radionuclide therapy with [177Lu-DOTA,Tyr3]octreotate in patients with bronchial and gastroenteropancreatic neuroendocrine tumours
    van der Zwan, W. A.
    Brabander, T.
    Kam, B. L. R.
    Teunissen, J. J. M.
    Feelders, R. A.
    Hofland, J.
    Krenning, E. P.
    de Herder, W. W.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (03) : 704 - 717
  • [27] Salvage peptide receptor radionuclide therapy with [177Lu-DOTA,Tyr3]octreotate in patients with bronchial and gastroenteropancreatic neuroendocrine tumours
    W. A. van der Zwan
    T. Brabander
    B. L. R. Kam
    J. J. M. Teunissen
    R. A. Feelders
    J. Hofland
    E. P. Krenning
    W. W. de Herder
    European Journal of Nuclear Medicine and Molecular Imaging, 2019, 46 : 704 - 717
  • [28] Peptide Receptor Radionuclide Therapy for Advanced Neuroendocrine Tumors
    Bodei, Lisa
    Cremonesi, Marta
    Kidd, Mark
    Grana, Chiara M.
    Severi, Stefano
    Modlin, Irvin M.
    Paganelli, Giovanni
    THORACIC SURGERY CLINICS, 2014, 24 (03) : 333 - +
  • [29] Peptide receptor radionuclide therapy for patients with advanced pancreatic neuroendocrine tumors
    Ramage, John
    Naraev, Boris G.
    Halfdanarson, Thorvardur R.
    SEMINARS IN ONCOLOGY, 2018, 45 (04) : 236 - 248
  • [30] Safety and efficacy of peptide receptor radionuclide therapy with 177Lu-DOTA-EB-TATE in patients with metastatic neuroendocrine tumors
    Jiang, Yuanyuan
    Liu, Qingxing
    Wang, Guochang
    Sui, Huimin
    Wang, Rongxi
    Wang, Jiarou
    Zhang, Jingjing
    Zhu, Zhaohui
    Chen, Xiaoyuan
    THERANOSTICS, 2022, 12 (15): : 6437 - 6445
12345